These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9296084)

  • 1. [Tricentric study of the sensitivity of Pseudomonas aeruginosa serotyping to beta-lactams and aminoglycosides].
    Vachée A; Scheftel JM; Husson MO; Izard D; Ross P; Monteil H
    Pathol Biol (Paris); 1997 May; 45(5):357-62. PubMed ID: 9296084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sensitivity to fosfomycin of multiresistant serotype 012 Pseudomonas aeruginosa. Multicenter study].
    Dubrous P; Cavallo JD; Buisson Y
    Pathol Biol (Paris); 1997 Jun; 45(6):472-8. PubMed ID: 9309262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the activity of beta-lactams against Pseudomonas aeruginosa according to phenotypes of resistance].
    Bert F; Briaud I; Branger C; Lambert-Zechovsky N
    Pathol Biol (Paris); 1996 May; 44(5):329-32. PubMed ID: 8758469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study].
    Cavallo JD; Leblanc F; Fabre R
    Pathol Biol (Paris); 2000 Jun; 48(5):472-7. PubMed ID: 10949844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pseudomonas aeruginosa: bactericidal activity on various beta-lactam resistance phenotypes of 8 antibiotics and 7 combinations].
    Dubrous P; Cavallo JD; Hernandez E; Nordmann P; Fabre R
    Pathol Biol (Paris); 1997 May; 45(5):433-7. PubMed ID: 9296099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro effect of various antibiotics: beta lactams, aminoglycosides and fluoroquinolones alone and in combination against P. aeruginosa isolated from patients with mucoviscidosis].
    Croize J; Gout JP; Robert J; Le Noc P
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):573-7. PubMed ID: 2508041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microbiological study of 386 strains of Pseudomonas aeruginosa isolated in a 30-month span in the Isernia area with special reference to an antimicrobial assay carried out with the ABAC system on 214 of them].
    Laurelli T; Ricci N; Ottaviano R; Manuppella AM; Petescia G
    Quad Sclavo Diagn; 1985 Dec; 21(4):469-82. PubMed ID: 3939383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro bactericidal activity of tobramycin and amikacin alone or in combination against Pseudomonas aeruginosa isolated from patients with cystic fibrosis].
    Bertrou A; Marty N; Henry S; Agueda L; Chabanon G
    Pathol Biol (Paris); 1990 May; 38(5):366-75. PubMed ID: 2114606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic susceptibility and mechanisms of beta-lactam resistance among clinical strains of Pseudomonas aeruginosa: first report in Algeria.
    Drissi M; Ahmed ZB; Dehecq B; Bakour R; Plésiat P; Hocquet D
    Med Mal Infect; 2008 Apr; 38(4):187-91. PubMed ID: 18395380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Pseudomonas aeruginosa to antimicrobials: a 2004 French multicentre hospital study.
    Cavallo JD; Hocquet D; Plesiat P; Fabre R; Roussel-Delvallez M;
    J Antimicrob Chemother; 2007 May; 59(5):1021-4. PubMed ID: 17412726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The resistance patterns and serotypes of Pseudomonas aeruginosa strains isolated from children.
    Patzer J; Dzierzanowska D
    J Antimicrob Chemother; 1991 Dec; 28(6):869-75. PubMed ID: 1816183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro sensitivity at 18 antibiotics of 192 strains of Pseudomonas aeruginosa isolated at Garches Hospital].
    Ronco E; Vacheron F; Orabona A
    Pathol Biol (Paris); 1987 May; 35(5):558-62. PubMed ID: 3112708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiological studies of the susceptibility of Pseudomonas aeruginosa to antibiotics].
    Bert F; Bruneau B; Lambert-Zechovsky N; Branger C
    Pathol Biol (Paris); 1994 May; 42(5):491-7. PubMed ID: 7824320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa.
    Patzer J; Gieburowska R; Dzierzanowska D
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics.
    Watine J; Bourrel C; Dubourdieu B; Gineston JL; Bories P; Durand M; Marre A; Formosa F; Brunel MP; Palliez J
    Pathol Biol (Paris); 1994 Apr; 42(4):293-5. PubMed ID: 7808781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
    Jones RN; Kirby JT; Beach ML; Biedenbach DJ; Pfaller MA
    Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa].
    Cluzel M; Chanal M; Sirot J; Cluzel R
    Nouv Presse Med; 1982 Nov; 11(46):3400-4. PubMed ID: 6818523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sensitivity of Pseudomonas aeruginosa to amikacin and to isepamicin in surgery and in intensive care].
    Vincent P; Vachée A; Izard D
    Pathol Biol (Paris); 1997 Nov; 45(9):771-5. PubMed ID: 9538477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.